Top 10 Healthcare Equipment Stocks To Watch For 2014

With Brazil's economy continuing to develop, the spread of wealth has affected the automotive industry in a very positive way. Compared to 2012, this year has seen some dynamic growth in auto sales and production. Foreign automakers such as Ford (NYSE: F  ) and General Motors (NYSE: GM  ) have been popular carmakers with new car owners in Brazil. Both companies have seen sales grow there and are certainly hoping the trend will continue.�

All 1.4 million cars that were sold between January and May have to fuel up somehow, and that is where Brazilian powerhouse Petrobras (NYSE: PBR  ) comes in to the picture. As the largest energy company in the country, Petrobras' gasoline sales would�presumably�follow a similar growth trajectory as auto sales once the retirement of old vehicles is taken into consideration. If the gap between international fuel prices is allowed to be closed ��the recent diesel price hike in March assisted with this ��then revenue from the company's downstream could really take off.

Hot Dividend Companies For 2015: ZipRealty Inc.(ZIPR)

ZipRealty, Inc., a residential real estate brokerage company, provides brokerage services to buyers and sellers in the United States. The company, through its Website ziprealty.com, provides access to Multiple Listing Services (MLS) home listings data, including pictures from the local MLSs; and allows consumers to receive an automatic email notification each time a property that meets their desired search criteria, is made available on the local MLSs. Its Website also offers neighborhood data, such as population, comparable home sales, average income, education level, occupation mix, cost of living, crime statistics, weather, school district information, maps, and driving directions; online images and virtual tours; schedule visits; and home offers. In addition, the company operates ZAP, a Web-based agent platform and customer relationship management system integrated to its Website. Its ZAP integrates and records consumer contact information and Website behavior, agent b ehavior, and transaction information into a common platform; and records relevant consumer behavior, such as logon frequency and times, specific homes viewed and printed, searches made by clients, requested visits to view homes, and online offers, as well as captures and stores agent activities, including agent email communications organized by clients. The company offers its services through its agents in Arizona, California, Colorado, Connecticut, Delaware, Florida, Georgia, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, North Carolina, Oregon, Pennsylvania, South Carolina, Texas, Utah, Virginia, Washington, and Washington, D.C. ZipRealty, Inc. was founded in 1999 and is based in Emeryville, California.

Advisors' Opinion:

• [By Shaun Currie, CFA]

  ZipRealty (ZIPR) is a company that meets 5 of the 6 criteria listed above. The stock has fallen out of favor over the last several years as performance declined during the recession. The company has completed a major restructuring and recently returned to positive EBITDA margins. Operations of the company are further supported by a pickup in home sales in the US. There has also been significant insider buying over the past month, and the company trades at a deep discount to its competition. I believe the stock has at least 60% upside from its current price.

Top 10 Healthcare Equipment Stocks To Watch For 2014: Forest Laboratories Inc (FRX)

Forest Laboratories, Inc. (Forest), incorporated on April 11, 1956, develops, manufactures and sells branded forms of ethical drug products, most of which requires a physician's prescription. The Company also focuses on the development and introduction of new products, including products developed in collaboration with licensing partners. Its products include those developed by the Company and those acquired from other pharmaceutical companies and integrated into its marketing and distribution systems. The Company�� principal products include Lexapro, its selective serotonin reuptake inhibitor (SSRI) for the treatment of major depressive disorder (MDD) in adults and adolescents and generalized anxiety disorder (GAD) in adults; Namenda, its N-methyl-D-Aspartate (NMDA) antagonist for the treatment of moderate and severe Alzheimer's disease; Bystolic, its beta-blocker for the treatment of hypertension; Savella, its selective serotonin and norepinephrine reuptake inhibitor (SNRI) for the management of fibromyalgia and its newest marketed product Teflaro, a broad-spectrum hospital-based injectable cephalosporin antibiotic for the treatment of adults with community-acquired bacterial pneumonia. On April 13, 2011, the Company acquired Clinical Data Inc. (Clinical Data), a specialty pharmaceutical company.

Aclidinium

In June 2011, the Company ahs submitted a New Drug Application (NDA) to the Food and Drug Administration (FDA) for aclidinium (aclidinium bromide), a long-acting antimuscarinic agent developed as an inhaled therapy for the maintenance treatment of chronic obstructive pulmonary disease (COPD). When given by inhalation, aclidinium leads to bronchodilation by inhibiting airway smooth muscle contraction. Aclidinium is rapidly hydrolyzed in human plasma to two major inactive metabolites. Aclidinium is administered to patients using a multi-dose dry powder inhaler (MDPI). This inhaler was designed with a feedback system which, through a ��olored control window��and an a! udible click, helps confirm that the patient has inhaled correctly. It contains multiple doses of aclidinium, includes a visible dose-level indicator, and also incorporates features such as an anti-double dosing mechanism and an end-of-dose lock-out system to prevent use of an empty inhaler.

Linaclotide

Linaclotide is being investigated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C) and chronic constipation (CC). Linaclotide is an agonist of the guanylate cyclase type-C receptor found in the intestine and acts by a mechanism. Linaclotide increases fluid secretions leading to increased bowel movement frequency and reduces abdominal pain. Linaclotide is administered orally but acts locally in the intestine with no measurable systemic exposure at therapeutic doses and is intended for once-daily administration.

Viibryd

As a result of its acquisition of Clinical Data, Inc. (Clinical Data) completed in April 2011, the Company obtained worldwide rights to develop and market Viibryd (vilazodone HCl) a selective serotonin reuptake inhibitor and a 5-HT1A receptor partial agonist developed by Clinical Data for the treatment of adults with major depressive disorder (MDD). Viibryd became available to patients during the June 2011 quarter and was formally launched in the U.S. in late August 2011.

Daliresp

In February 2011, the Company received approval from the United States Food and Drug Administration (FDA) for the marketing of Daliresp (roflumilast). Daliresp is once-daily, orally administered, selective phosphodiesterase 4 (PDE4) enzyme inhibitor, developed by its partner, Nycomed GmbH (Nycomed), as a treatment to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations.

Namenda

Namenda (memantine HCl) is an N-methyl-D-Aspartate (NMDA) receptor agonist for the treatmen! t of mode! rate and severe Alzheimer�� disease. In June 2010, Namenda XR was approved by the FDA for the treatment of moderate to severe dementia of the Alzheimer�� type. Namenda XR is a 28 milligrams once-daily extended-release formulation of Namenda. The Company has obtained the exclusive rights to develop and market memantine in the United States by license agreement with Merz Pharma GmbH & Co. KgaA (Merz) of Germany, the originator of the product.

Bystolic

Bystolic is a beta-1 selective beta-blocker with vasodilating properties. Bystolic decreases heart rate and myocardial contractility and suppresses rennin activity. The Company licensed exclusive United States and Canadian rights to Bystolic from Mylan Inc. (Mylan).

Savella

Savella (milnacipran HCl) is the Company�� selective serotonin and norepinephrine inhibitor (SNRI) for the management of fibromyalgia. Fibromyalgia is a chronic condition characterized by widespread pain and decreased physical function. The Company licensed the United States and Canadian rights to develop and commercialize Savella from Cypress Bioscience, Inc. (Cypress). Its license agreement includes two patents covering the use of Savella for the management of fibromyalgia.

Teflaro

In October 2010, the Company received marketing approval from the FDA for Teflaro (ceftaroline) for the treatment of adults with community-acquired bacterial pneumonia, including cases caused by Streptococcus pneumoniae bacteremia and with acute bacterial skin and skin structure infections, including cases caused by methicillin-resistant Staphylococcus aureus. Teflaro is a spectrum, hospital-based injectable cephalosporin antibiotic with activity against Gram-positive bacteria and common Gram-negative bacteria. Teflaro is a member of the cephalosporin class of antibiotics. The worldwide rights (excluding Japan) to Teflaro are in-licensed on an exclusive basis from Takeda Pharmaceutical Company (Takeda). Teflaro is als! o covered! by two United States patents that relate to the ceftaroline formulation that expire in 2021 and that may provide additional exclusivity.

Avibactam

Avibactam is designed to be co-administered with select antibiotics to enhance their spectrum of activity. The Company received the exclusive rights to administer avibactam with ceftaroline as a combination product in North America. Avibactam is a beta-lactamase inhibitor designed to be co-administered with select antibiotics to enhance their spectrum of activity by overcoming beta-lactamase-related antibacterial resistance.

Lexapro

Lexapro�� is a SSRI for the treatment of MDD in adults and adolescents and GAD in adults. Lexapro�� (escitalopram oxalate) single isomer version of citalopram HBr, for the treatment of MDD in adults and adolescents and GAD in adults.

Cariprazine

Cariprazine is an oral D2/D3 partial agonist. Cariprazine is also undergoing Phase III trials for schizophrenia and acute mania associated with bipolar depression, bipolar depression and as an adjunct treatment for MDD.

Levomilnacipran

Levomilnacipran is a once-daily, selective norepinephrine and serotonin reuptake inhibitor, two neurotransmitters known to play an essential role in regulating mood, and is being developed for the treatment of MDD.

GRT 6005

In December 2010, the Company entered into a license agreement with Grunenthal GmbH for the co-development and commercialization of GRT 6005 and its follow-on compound GRT 6006, small molecule analgesic compounds being developed by Grunenthal for the treatment of moderate to severe chronic pain. GRT 6005 and GRT 6006 are compounds with pharmacological and pharmacokinetic profiles that may enhance their effect in certain pain conditions. GRT 6005 has completed initial proof-of-concept studies in nociceptive and neuropathic pain with further Phase II studies planned prior to initiation of Phase III s! tudies.

TTP399

In June 2010, the Company entered into a license agreement with TransTech Pharma, Inc. (TransTech) for the development and commercialization of TTP399, a functionally liver selective glucokinase activator (GKA) discovered and developed by TransTech for the treatment of Type II diabetes. Early Phase I testing suggests that pharmacological enhancement of glucokinase activity may lower blood glucose in diabetic patients.

Azimilide

In April 2011, the Company entered into an agreement with Blue Ash Therapeutics, LLC (Blue Ash) pursuant to which it acquired the worldwide rights to azimilide, a class III antiarrhythmic agent developed by Proctor & Gamble Pharmaceuticals. Based on its mechanism of action and results of clinical trials, azimilide was determined to be suited for use in patients with a history of life-threatening ventricular arrhythmias and who have an implantable cardioverter defibrillator. In 2010, the FDA agreed to one additional Phase III study to support a regulatory submission for azimilide in the U.S.

RGH-618

RGH-618 involves a series of compounds that target metabotropic glutamate receptors and are agonists, which represent potential agents for the treatment of anxiety, depression and other central nervous system (CNS) conditions. In March 2012, the Company initiated a Phase I study in healthy volunteers of RGH-618.

Advisors' Opinion:

• [By Sean Williams]

  Believe it or not, Forest Laboratories (NYSE: FRX  ) continued its string of good news following word from the Food and Drug Administration on Friday that Fetzima, a drug co-developed with Pierre Fabre Laboratories, had been approved to treat major depressive disorder. This is a big step for Forest Labs, which lost MDD drug Lexapro to patent expiration last year and now could be set to capitalize on a disease that can affect as many as 15 million people in the U.S. -- all with Eli Lilly's�Cymbalta, a $5 billion-a-year drug, set to lose patent protection itself in the fourth quarter.

Top 10 Healthcare Equipment Stocks To Watch For 2014: Marcolin SpA (MCL)

Marcolin SpA is an Italy-based eyewear manufacturer. It is a manufacturer of glasses and sunglasses for such brands as Tom Ford, Roberto Cavalli and Just Cavalli, Diesel, Montblanc, Tod's and Hogan, Balenciaga, Swarovski, Timberland, DSquared2 and Kenneth Cole. Advisors' Opinion:

• [By John McCamant]

  Our top stock selection for 2014 has received three Breakthrough Therapy Designations (BTD) by the FDA, and subsequent approval, in November, for Imbruvica, a very safe pill that has shown unprecedented efficacy to treat mantle cell lymphoma (MCL), suggests John McCamant, editor of The Medical Technology Stock Letter.

Top 10 Healthcare Equipment Stocks To Watch For 2014: Taylor Morrison Home Corp (TMHC)

Taylor Morrison Home Corporation, incorporated on November 15, 2012, is a homebuilder in North America. The Company operates under its Taylor Morrison brand in the United States and under its Monarch brand in Canada. Its business is organized into three geographic regions: East, West and Canada. Its East region consists of its Houston, Austin, North Florida and West Florida divisions. Its West region consists of its Phoenix, Northern California, Southern California and Denver divisions. Its Canada region consists of its operations within the province of Ontario, primarily in the Greater Toronto Area (GTA) and also in Ottawa and Kitchener-Waterloo, and offers both single-family and high-rise communities.

As of September 30, 2012, the Company offered homes in 122 active selling communities and had a backlog of 4,205 homes sold but not closed, including 903 homes in unconsolidated joint ventures. During the year ended September 30, 2012, the Company closed 2,586 homes, consisting of 1,880 homes in the United States and 706 homes in Canada, including 204 homes in unconsolidated joint ventures.

Our Homes

The Company offers a range of homes to consumers in its markets, ranging from entry-level to luxury homes. The Company market single-family homes with many amenities to entry-level through move-up homebuyers. The Company has developed a number of home designs with features such as one-story living and first floor master bedroom suites to appeal to universal design needs, as well as communities with recreational amenities such as golf courses, pool complexes, country clubs and recreation centers. The Company has integrated these designs and features in many of its homes and communities. The Company offers some of the same basic home designs in similar communities and engages unaffiliated architectural firms to develop new designs to replace or augment existing ones in order to ensure that our homes reflect current and local consumer tastes.

Warranty Progr! am

The Company offers express written limited warranties on our homes that generally provide for one year of coverage for various defects in workmanship or materials. These warranties are in addition to certain legal warranties (including implied warranties) that may apply in the markets where the Company operates. In Canada, in accordance with regulatory requirements administered by the Tarion Warranty Corporation, the Company offers a limited warranty that generally provides for seven years of structural coverage, two years of coverage for water penetration, electrical, plumbing, heating, and exterior cladding defects, and one year of coverage for workmanship and materials.

Community Development

The Company aims to establish a complete concept for each community the Company develops, beginning with an overall community design and then determining the size, style and price range of the homes and the layout of the streets and individual home sites. In the case of developed communities, after necessary governmental subdivision and other approvals have been obtained, the Company improve the land by clearing and grading it, installing roads, installing underground utility lines and recreational amenities, erecting distinctive entrance structures and staking out individual home sites.

Customer Mortgage Financing

Taylor Morrison Home Funding, LLC (TMHF) provides a number of mortgage-related services to its homebuilding customers through its mortgage lending operations. TMHF�� multi-lender platform included Flagstar Bank, US Bank, SunTrust Bank, Wells Fargo Mortgage and Metlife Home Loans. Revenue was derived from yield spread premiums, broker points and processing fees. The main strategic purpose of TMHF in its business is: to utilize finance as a sales tool as part of the purchase process to ensure a consistent customer experience and assist in maintaining production efficiency; and to influence and assist in determining its backlog and ! to better! manage projected closing and delivery dates for its customers.

Advisors' Opinion:

• [By shash63]

  Taylor Morrison (TMHC) is the eighth-largest U.S. homebuilder in terms of revenue. The increase in home prices and strong demand for homes has made Southwest Florida a good investment option for residential construction companies. There are more buyers than sellers in this market, which is driving up home prices. Looking at the growth opportunity, the company is rapidly expanding in Southwest Florida and has undertaken several projects. It is developing a resort lifestyle community of 443 single-family homes and a Golf and Country Club community with 1,121 single-family homes. It expects to increase its community count by 30% in 2014. The rising number of communities is expected to increase Taylor Morrison�� revenue by 53% to $2.19 billion in 2013 and around $3.01 billion in 2014 to $3.36 billion in 2015.

• [By DailyFinance Staff]

  LM Otero, AP The housing market has been leading the economic recovery, but have housing stocks hit the ceiling? They're jumping today after a very bullish report on housing starts: New construction projects last month topped the 1 million annual rate for the time since before the financial crisis began in 2008. That's lifted shares of leading homebuilders by two to four percent today, adding to the huge gains over the past year. KB Homes (KBH), Pulte (PHA) and Hovnanian (HOV) have all doubled in price over the past year. Lennar (LEN) is up 44 percent, D.R. Horton (DHI) is up 47 percent and Toll Brothers (TOL) 33 percent. Those gains have prompted several other builders to go public this year. Taylor Morrison Home (TMHC), Tri Pointe, and William Lyon Home have all moved higher since their IPOs. And even though there's plenty of optimism that housing will continue to lead the broader economic recovery, there's some concern that these stocks may slow down. Homebuilder stocks can no longer be considered cheap. So some analysts see alternate routes for investors looking to play the housing boom. One way is through home-improvement retailers, which benefit from sales of both new and existing homes. Other plays include lumber, furniture and appliance companies. It's also worth noting that today's report on home construction showed that starts of single-family homes actually declined in March. It was the more volatile multi-family sector that led the advance. But there may be some stock market opportunities in REITs – real estate investment trusts – which focus on apartments. Among the biggest ones are Post Properties, Essex Property Trust and Associated Estates. They make money from collecting monthly rents. And these stocks generally trade below the value of the properties they own. Even some builders known for single-family homes are moving into the multi-family segment. Lennar announced in January that it plans to enter the apartment rental mar

Top 10 Healthcare Equipment Stocks To Watch For 2014: Ten Peaks Coffee Company Inc (TPK)

Ten Peaks Coffee Company Inc. (Ten Peaks) is a Canada-based company. It operates its business through its subsidiary, Swiss Water Decaffeinated Coffee Company Inc. (SWDCC), which is a green coffee decaffeinator located in Burnaby, British Columbia. It also owns and operates Seaforth Supply Chain Solutions Inc. (Seaforth), a green coffee handling and warehousing business located in Metro Vancouver. SWDCC is engaged in the coffee decaffeination business utilizing the branded Swiss Water Process of 100% chemical free green coffee decaffeination. SWDCC has two subsidiaries, which include Swiss Water Decaffeinated Coffee Co. USA, Inc, and Swiss Water Process Marketing Services Inc. On November 18, 2011, a subsidiary of Ten Peaks, Seaforth Supply Chain Solutions Inc., was incorporated. On January 1, 2011, in response to changes to the legislation governing the taxation of income trusts which made the income trust form of structure less advantageous, the Fund converted to a corporation. Advisors' Opinion:

• [By Inyoung Hwang]

  Travis Perkins Plc (TPK) lost 1.6 percent to 1,749 pence. The builders��merchant said its consumer division failed to grow on a comparable basis in the third quarter, slipping from an 8.6 percent increase in the two months ended June.

Top 10 Healthcare Equipment Stocks To Watch For 2014: Red Robin Gourmet Burgers Inc.(RRGB)

Red Robin Gourmet Burgers, Inc., together with its subsidiaries, develops, operates, and franchises casual-dining restaurants in the United States and Canada. As of February 16, 2012, the company operated 465 Red Robin restaurants, including 328 company-owned restaurants and 137 restaurants operating under franchise agreements. Its restaurants offer gourmet burgers, as well as various salads, soups, appetizers, entrees, desserts, and signature Mad Mixology alcoholic and non-alcoholic specialty beverages Red Robin Gourmet Burgers, Inc. was founded in 1969 and is headquartered in Greenwood Village, Colorado.

Advisors' Opinion:

• [By John Udovich]

  On Tuesday, small cap casual dining stock Red Robin Gourmet Burgers, Inc (NASDAQ: RRGB) was bucking the Dow to head higher after earnings, meaning its worth looking more closely at the stock to see what its doing right in the fickle restaurant space�plus take a look at the�performance of potential (non-fast food) peers like Frisch's Restaurants, Inc (NYSEMKT: FRS) and Sonic Corporation (NASDAQ: SONC).

• [By Tim Beyers]

  Have you tried the new "Berserker" burger at Red Robin (NASDAQ: RRGB  ) ? I have, and as an investor, I find it to be a spicy and delicious triumph of Walt Disney (NYSE: DIS  ) licensing.

• [By Dan Caplinger]

  Still, the stock's performance reflects overall enthusiasm about restaurant chains generally. Red Robin Gourmet Burgers (NASDAQ: RRGB  ) struggled mightily during the recession, but its stock has bounced back convincingly, with gains sending shares to levels not seen since 2005. Even Brinker International (NYSE: EAT  ) , which cut its estimates on same-store sales growth to just 1%, and guided earnings to the lower end of its previous range, has seen its stock soar in anticipation of better times ahead.

• [By Lisa Levin]

  Red Robin Gourmet Burgers (NASDAQ: RRGB) shares climbed 3.04% to $54.23. The volume of Red Robin shares traded was 398% higher than normal. On Thursday, Red Robin reported downbeat second-quarter profit.

Top 10 Healthcare Equipment Stocks To Watch For 2014: AMREP Corp (AXR)

AMREP Corporation, incorporated on August 7, 1987, through its subsidiaries, is engaged in four business segments: the Subscription Fulfillment Services business operated by Palm Coast Data LLC (Palm Coast), the Newsstand Distribution Services business, the Product Services and Other businesses operated by Kable Media Services, Inc. and its subsidiaries (Kable) (the businesses operated by Palm Coast and Kable are collectively referred to as Media Services), and the real estate business operated by AMREP Southwest Inc. and its subsidiaries (collectively, AMREP Southwest). The Company, through its Palm Coast subsidiary, conducts its Subscription Fulfillment Services business, in which it performs subscription fulfillment and related services for publishers and other customers; through its Kable Newsstand Distribution Services subsidiary distributes periodicals nationally and in Canada and in other foreign countries, and through its Kable Product Services, Specialty Packaging Services and Staffing Resources subsidiaries, provides Internet order processing and shipment for e-commerce retailers, packaging design, procurement and product fulfillment services and temporary staffing services. In January 2013, the Company's subsidiary, had acquired certain assets of FulCircle, Inc.

Subscription Fulfillment Services

The Subscription Fulfillment Services business performs fulfillment and fulfillment-related activities, principally magazine subscription fulfillment services and ancillary services. During the fiscal year ended April 30, 2012 (fiscal 2012), it accounted for approximately 75% of Media Services revenues. In the magazine subscription fulfillment services operation, Palm Coast maintains subscriber lists and databases, processes new orders, receives and accounts for payments, prepares and transmits to each publisher�� printer the labels or tapes containing the names and addresses of subscribers for mailing each issue, handles subscriber telephone inquiries and correspondence,! prepares renewal and statement notifications for mailing, generates marketing and statistical reports, processes Internet orders and prints forms and promotional materials. List services clients are publishers for whom Palm Coast maintains client customer lists, selects names for clients who rent their lists, merges rented lists with a client�� lists to eliminate duplication for the client�� promotional mailings, and sorts and sequences mailing labels. Palm Coast performs subscription fulfillment services for approximately 450 different magazine titles for approximately 110 clients and maintains databases of approximately 41 million active subscribers for its client publishers and membership organizations.

Newsstand Distribution Services

In the Company�� Newsstand Distribution Services business, Kable distributes over 450 publications for approximately 200 publishers. Among the titles are special interest magazines, including hobbyist, celebrity, puzzle, automotive, comics, women�� service and sports magazines. In a typical month, Kable distributes approximately 47 million copies of various titles to wholesalers. Kable coordinates the movement of the publications from its publisher clients to approximately 100 independent wholesalers in North America and to wholesalers in over 80 countries globally. The wholesalers in turn sell the publications to retail chains and independent retail outlets. During fiscal 2012, the Newsstand Distribution Services business accounted for approximately 11% of Media Services revenues. Kable generates and delivers to each publisher�� printer shipping instructions with the addresses of the wholesalers and the number of copies of product to be shipped to each.

Product Services and Other

Together, Kable Product Services and Kable Specialty Packaging Services (collectively, Product Services) offer an integrated approach to electronic and traditional commerce for consumer products manufacturers, including both publ! ishing an! d non-publishing customers. The business unit provides account management by customer; design, procurement, and packaging of retail packs and point-of-purchase displays; front-end processing, including customer out-reach through e-commerce, direct mail and phone; order capturing through electronic mediums, as well as traditional call center operations, mail capture and entry; warehousing and pick/pack/ship functions, including analysis of shipping methods, and billing, as well as collection of payments tendered by credit cards, checks and cash.

As an adjunct to the Subscription Fulfillment Services business, Product Services offers fulfillment services to their publishers, including shipment of premiums (free gifts) provided to subscribers, shipment of replacement copies of newly issued magazines or purchased copies of older editions and shipment and payment processing for product advertised for sale in their publishers��magazines or associated Websites. Kable Staffing Resources (Staffing Resources) operates as a separate business, which provides temporary employees to local companies in the Fairfield, Ohio area, including its affiliate Product Services. During fiscal 2012, together, they accounted for approximately 14% of Media Services revenues in 2012.

Real Estate Operations

The Company conducts its Real Estate business through AMREP Southwest, with these activities occurring in the City of Rio Rancho and adjoining areas of Sandoval County, New Mexico. Rio Rancho consists of 91,049 acres in Sandoval County near Albuquerque, of which approximately 74,100 acres have been platted into approximately 114,680 residential and commercial lots, approximately 16,500 acres are dedicated to community facilities, roads and drainage and the remainder is unplatted land. As of April 30, 2012, approximately 91,000 of these residential and commercial lots had been sold by AMREP Southwest net of lots repurchased and those returned to AMREP Southwest by deeds in lieu of foreclosu! re. As of! April 30, 2012, AMREP Southwest owns approximately 17,350 acres in Rio Rancho, of which approximately 4,415 acres are in several areas of contiguous properties, which are being developed or are suitable for development, and approximately 2,000 acres are in areas with a concentration of ownership, where AMREP Southwest owns more than 50% of the lots in the area.

At Rio Rancho, AMREP Southwest develops both residential lots and sites for commercial and industrial use as demand warrants, and also secures entitlements for development tracts for sale to homebuilders. AMREP Southwest also owns two tracts of land in Colorado, consisting of one property of approximately 160 acres planned for approximately 400 homes that AMREP Southwest focuses to offer for sale upon obtaining all necessary entitlements, and one property of approximately 10 acres zoned for commercial use.

Advisors' Opinion:

• [By Damian Illia]

  As we can see, the firm has a higher ROE than Amrep Corporation (AXR) but is well below the one registered by US Ecology Inc. (ECOL) and Cintas Corporation (CTAS).